3F7D image
Entry Detail
PDB ID:
3F7D
Keywords:
Title:
SF-1 LBD bound by phosphatidylcholine
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2008-11-07
Release Date:
2008-12-09
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.24
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:nuclear receptor SF-1
Mutations:C302S, C408S, C413S, C423S, C267(CAF)
Chain IDs:A
Chain Length:244
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:Peroxisome proliferator-activated receptor gamma coactivator 1-alpha
Chain IDs:B
Chain Length:14
Number of Molecules:1
Biological Source:Mus musculus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CAF A CYS S-DIMETHYLARSINOYL-CYSTEINE
Ligand Molecules
Primary Citation
Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands.
Mol.Endocrinol. 23 25 34 (2009)
PMID: 18988706 DOI: 10.1210/me.2007-0508

Abstact

Despite the fact that many nuclear receptors are ligand dependent, the existence of obligate regulatory ligands is debated for some receptors, including steroidogenic factor 1 (SF-1). Although fortuitously bound bacterial phospholipids were discovered in the structures of the SF-1 ligand-binding domain (LBD), these lipids might serve merely as structural ligands. Thus, we examined whether exogenously added phospholipids would exchange for these bacterial lipids and bind to SF-1. Here, we report the first crystal structure of the SF-1 LBD bound by the exchanged phosphatidylcholine. Although the bound phosphatidylcholine phospholipid mimics the conformation of bound bacterial phosphoplipids, two surface loops, L2-3 and L11-12, surrounding the entrance to the pocket vary significantly between different SF-1 LBD structures. Based on this observation, we hypothesized that a bound ligand might control the conformations of loops L2-3 and L11-12, and that conserved residues in these dynamic loops could influence ligand binding and the receptor function. Consistent with this hypothesis, impaired phospholipid exchange and diminished transcriptional activity were observed for loop L11-12 SF-1 mutants and for the loop L2-3 human mutant R255L. The endocrine disease associated with this L2-3 mutation coupled with our cellular and biochemical data suggest that critical residues at the mouth of the ligand-binding pocket have evolved for efficient binding of phospholipid ligands and for achieving optimal SF-1 activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures